TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
JMVA Biotech AB
Closing information (x1000 NOK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
1,220
|
1,260
|
1,976 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
342
|
214
|
832 |
| EBITDA |
340
|
214
|
832 |
| Total assets |
2,072
|
2,327
|
2,461 |
| Current assets |
2,072
|
2,327
|
2,461 |
| Current liabilities |
14
|
190
|
31 |
| Equity capital |
1,996
|
2,072
|
2,360 |
| - share capital |
47
|
49
|
52 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
96.3%
|
89.0%
|
95.9% |
| Turnover per employee |
1,220
|
1,260
|
1,976 |
| Profit as a percentage of turnover |
28.0%
|
17.0%
|
42.1% |
| Return on assets (ROA) |
16.5%
|
9.2%
|
33.8% |
| Current ratio |
14800%
|
1224.7%
|
7938.7% |
| Return on equity (ROE) |
17.1%
|
10.3%
|
35.3% |
| Change turnover |
-2
|
-579
|
-181 |
| Change turnover % |
0%
|
-31%
|
-8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.